In AL amyloidosis, amyloid fibrils, composed of abnormal light chain proteins, are produced by abnormal plasma cells in the bone marrow. AL amyloidosis is a plasma cell disorder but as the plasma cells are not truly cancerous, it is not regarded as a cancer. It is however closely related to myeloma and is diagnosed in…
This Good Practice Paper provides recommendations for the diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance (MGUS).
Read the paper here.
Laboratory staff play a key role in the investigation, diagnosis, and management of a range of plasma cell disorders including MGUS, AL amyloidosis and myeloma. In March 2023, we partnered with UKNEQAS to deliver four educational webinars covering these disorders. The webinars focus on defining the different types of plasma cell disorders, deciding when and…
The following questionnaire can determine if you are at risk of developing obstructive sleep apnea (OSA) by screening for 4 self-reportable and 4 demographic characteristics. Note this is Property of the University Health Network. Modified from Chung F et al. Anesthesiology 2008; 108: 812-821, Chung F et al Br J Anaesth 2012; 108: 768-775, Chung…
New treatment appraisals continue to come through the Health Technology Appraisal (HTA) pipeline.
Myeloma UK is involved in five active appraisals and one appeal at the National Institute for Healthcare Excellence (NICE).
Myeloma UK has partnered with the UK Myeloma Society to launch a digital infosession ‘BCMA and GPRC5D Antibodies in Practice: Implementation and management for healthcare professionals’. Find out how to register for free.
New research has uncovered a concerning gap in the time taken to diagnose myeloma between ethnic groups, with black people experiencing longer waits for a diagnosis than white people. The study showed that black patients diagnosed with myeloma had a median wait time of over one month longer than white people.
We are pleased to report that Royal Hampshire County Hospital, Ipswich Hospital, Belfast City Hospital, The Christie Hospital, HCA UK at University College Hospital, Southmead Hospital, Colchester Hospital and Freeman Hospital have all received Myeloma UK’s Clinical Service Excellence Programme (CSEP) award. Each hospital demonstrated excellent clinical practice with notable highlights.
